Gene Upshaw Memorial Tahoe Forest Cancer Center
Truckee, California, United States
Cancer treatment center in Truckee, California
10121 Pine Ave, Truckee, CA 96161
About Gene Upshaw Memorial Tahoe Forest Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
46
SWOG Cancer Research Network
35
NRG Oncology
14
Alliance for Clinical Trials in Oncology
10
ECOG-ACRIN Cancer Research Group
8
Radiation Therapy Oncology Group
2
American Society of Clinical Oncology
1
Bristol-Myers Squibb
1
Canadian Cancer Trials Group
1
NSABP Foundation Inc
1
Ohio State University Comprehensive Cancer Center
1
Clinical Trials at Gene Upshaw Memorial Tahoe Forest Cancer Center
During the past decade, Gene Upshaw Memorial Tahoe Forest Cancer Center conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 57 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 22 clinical trials were completed. i.e. 146.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
2004-04-01
2018-10-01
Completed
695
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gene Upshaw Memorial Tahoe Forest Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 46 trials, followed by "SWOG Cancer Research Network" with 35 trials
sponsored, "NRG Oncology" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 10 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 10 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gene Upshaw Memorial Tahoe Forest Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 72 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 25 different institutions and companies that were
collaborators in the rest 22 trials.
Clinical Trials Conditions at Gene Upshaw Memorial Tahoe Forest Cancer Center
According to Clinical.Site data, the most researched conditions in "Gene Upshaw Memorial Tahoe Forest Cancer Center" are
"Lung Cancer" (10 trials), "Breast Cancer" (9 trials), "Prostate Cancer" (7 trials), "Recurrent Breast Carcinoma" (5 trials) and "Recurrent Squamous Cell Lung Carcinoma" (5 trials). Many other conditions were trialed in "Gene Upshaw Memorial Tahoe Forest Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Gene Upshaw Memorial Tahoe Forest Cancer Center
Most popular intervention types in "Gene Upshaw Memorial Tahoe Forest Cancer Center" are "Drug" (93 trials), "Other" (65 trials), "Biological" (36 trials), "Radiation" (29 trials) and "Procedure" (23 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (33 trials), "Quality-of-Life Assessment" (22 trials), "Questionnaire Administration" (15 trials), "Cisplatin" (12 trials) and "Biospecimen Collection" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Gene Upshaw Memorial Tahoe Forest Cancer Center
The vast majority of trials in "Gene Upshaw Memorial Tahoe Forest Cancer Center" are
90 trials for "All" genders, 15 trials for "Female" genders and 15 trials for "Male" genders.
Clinical Trials Status at Gene Upshaw Memorial Tahoe Forest Cancer Center
Currently, there are NaN active trials in "Gene Upshaw Memorial Tahoe Forest Cancer Center".
undefined are not yet recruiting,
21 are recruiting,
55 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 34 completed trials in Gene Upshaw Memorial Tahoe Forest Cancer Center,
3 suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Gene Upshaw Memorial Tahoe Forest Cancer Center, 1 "Phase 1"
clinical trials were conducted, 54 "Phase 2" clinical
trials and 69 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".